<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B"><gtr:id>22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B</gtr:id><gtr:name>University of Ulm</gtr:name><gtr:address><gtr:line1>Albert Einstein Allee 5</gtr:line1><gtr:line4>Ulm</gtr:line4><gtr:postCode>89081</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Dept of Development &amp; Signalling</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B"><gtr:id>22FC5EB4-C5EC-4751-9C2E-7F03B1DC354B</gtr:id><gtr:name>University of Ulm</gtr:name><gtr:address><gtr:line1>Albert Einstein Allee 5</gtr:line1><gtr:line4>Ulm</gtr:line4><gtr:postCode>89081</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1367D45-734D-4891-9671-3C7C7C31D0A0"><gtr:id>D1367D45-734D-4891-9671-3C7C7C31D0A0</gtr:id><gtr:name>UCB Pharma</gtr:name><gtr:address><gtr:line1>Researchdreef 60</gtr:line1><gtr:line2>Allee de la Recherche 60</gtr:line2><gtr:postCode>B-1070</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Belgium</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/61D20CC7-787C-455B-936A-3E16D0122205"><gtr:id>61D20CC7-787C-455B-936A-3E16D0122205</gtr:id><gtr:name>Semmelweis University</gtr:name><gtr:address><gtr:line1>Semmelweis University</gtr:line1><gtr:line2>Alkotas u. 44</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/A8FFE8BD-0636-4C9D-A5F7-29460A47D865"><gtr:id>A8FFE8BD-0636-4C9D-A5F7-29460A47D865</gtr:id><gtr:firstName>Len</gtr:firstName><gtr:surname>Stephens</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/489B2175-D1F8-479D-87B2-2C791677D905"><gtr:id>489B2175-D1F8-479D-87B2-2C791677D905</gtr:id><gtr:firstName>Phillip</gtr:firstName><gtr:surname>Hawkins</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600840"><gtr:id>371AB048-8E29-494B-80FB-C313EEAFC32A</gtr:id><gtr:title>The role of PtdIns3P in the killing of bacteria and fungi by the neutrophil NADPH oxidase</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0600840</gtr:grantReference><gtr:abstractText>Neutrophils are white blood cells in our body which are responsible for finding, eating and killing nasty microbes. An important part of the killing process is the delivery of large quantities of toxic oxygen molecules into a specialist chamber inside the neutrophil called a phagosome, which contains the microbe. These toxic chemicals are made by an enzyme called the NADPH oxidase and we know it must be important because of the discovery of a rare disease called CGD (chronic granulomatous disease), where patients carrying mutations in one of the six proteins which make up this enzyme suffer life-threatening bacterial and fungal infections. The way in which the NADPH oxidase is turned on is complicated, because it has to switch on in response to eating a wide variety of different microbes but at the same time it mustn?t cause too much damage to surrounding body tissues. An understanding of how the NADPH oxidase works is thus likely to improve our understanding of what goes wrong when some infections and inflammations are not dealt with properly. The applicants have recently discovered that enzymes called PI3Ks may play a key role in regulating the NADPH oxidase by synthesising a messenger molecule around the phagosome called PtdIns3P, which they have shown binds tightly to one of the six NADPH oxidase components. They propose to use chemicals recently developed by the pharmaceutical industry to specifically block PI3Ks to assess their role in the synthesis of PtdIns3P and NADPH oxidase function. Most of these experiments will be done on neutrophils purified from human blood taken from local volunteers. The applicants have also created mutant mice in which the gene encoding the expression of the oxidase component which binds PtdIns3P has been altered to prevent this interaction. These mice are healthy and fertile when housed under pathogen-free conditions and they now propose to evaluate the effect of this mutation on the ability of these mice to combat bacterial and fungal infections; most of the experiments will be done on neutrophils purified from the bone marrow of these animals. This group has a strong track record in publishing their work in the public domain and are regularly asked to present their work at international conferences. They have also developed good links with the pharmaceutical industry and hence useful results from the work should be quickly disseminated.</gtr:abstractText><gtr:technicalSummary>The NADPH oxidase of neutrophils plays a key role in our defence against microbial pathogens. This is clearly evident from the life-threatening bacterial and fungal infections which present in cases of CGD, a disease caused by mutations in several of the components of this enzyme complex. The NADPH oxidase is responsible for directing the delivery of toxic reactive oxygen species into phagosomes where they play an important role in the killing of engulfed pathogens. The signalling pathways which lead to the appropriate assembly and activation of the oxidase are necessarily complex, both because of the wide variety of receptors which are required to trigger this event and the need for tight control to limit damage to host tissues. This proposal seeks to understand the role of phosphoinositide 3-kinase (PI3K) signalling pathways in NADPH oxidase activation and killing of specific bacteria and fungi.

There are seven different catalytic subunits of PI3Ks which fall into three functional classes; of relevance here are the class I and class III enzymes which synthesise the phospholipid messengers PtdIns(3,4,5)P3 and PtdIns3P, respectively. A major objective of this proposal is to use newly developed PI3K isoform-selective inhibitors and PI3K ?knock-out? mice to define the involvement of specific PI3Ks in human and mouse neutrophil phagocytosis, NADPH oxidase activation and killing of specific bacteria and fungi. The majority of these analyses will be carried out in vitro on neutrophils purified from human blood and mouse bone marrow. A second objective will be to measure PtdIns3P synthesis and subcellular localisation during selected examples of phagocytosis by confocal fluorescence imaging of neutrophils expressing GFP-tagged, PtdIns3P-binding domains. A third objective will be to measure the effects of a mutation in one of the components of the oxidase, p40phox, which prevents binding to PtdIns3P; this will be done by utilising p40phox R58A ?knock-in? mice recently created in the applicants? laboratory and will involve characterising NADPH oxidase responses in vitro and killing of bacteria and fungi both in vitro and in vivo. 

It is anticipated that the proposed work will define some important paradigms for how PI3Ks are used to regulate NADPH oxidase activity during infection and inflammation and the applicants are well placed to disseminate this information through publication in peer reviewed journals, presentations at scientific conferences and through good collaborations with the pharmaceutical industry.</gtr:technicalSummary><gtr:fund><gtr:end>2010-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>500878</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Faculty of Medicine</gtr:department><gtr:description>Role of Rab27 in neutrophil oxidase activation</gtr:description><gtr:id>EBB7793C-8562-4935-ABE1-0B13C12CA7BE</gtr:id><gtr:impact>PMID: 20813901 listed under 'publications'</gtr:impact><gtr:outcomeId>tUcQVUSJAj9-1</gtr:outcomeId><gtr:partnerContribution>Provided access to Rab27 knock-out mice</gtr:partnerContribution><gtr:piContribution>We provided the majority of the intellectual input and technical resources for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Semmelweiss University</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Role of Syk in neutrophil activation by Aspergillus</gtr:description><gtr:id>B96F614D-6AF6-4C6B-AE4B-78CC0FB10568</gtr:id><gtr:impact>Boyle KB et al (2011) J Immunol. 186(5):2978-89. doi: 10.4049/jimmunol.1002268.</gtr:impact><gtr:outcomeId>Az1voaYWKub-2</gtr:outcomeId><gtr:partnerContribution>Our collaborators provided access to two strains of knock-out mice (syk KO; Fcgamma/DAP12 double KO) and hosted a visit from Keith Boyle (post-doctoral scientist employed on grant) to their laboratory in Budapest to conduct experiments.</gtr:partnerContribution><gtr:piContribution>We took the intellectual lead in this project and contributed the majority of the work and reagents, including strains of mice deficient in PI3K and NADPH oxidase subunits</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Role of Rac proteins in neutrophil oxidase activation by bacteria</gtr:description><gtr:id>F70E85FB-6B54-427D-89BF-9C38E02B604D</gtr:id><gtr:impact>PMID: 20813901 listed under 'publications'</gtr:impact><gtr:outcomeId>Wjjc7raTkJT-1</gtr:outcomeId><gtr:partnerContribution>Provided access to Rac1 knock-down and Rac2 knock-out mouse strains</gtr:partnerContribution><gtr:piContribution>We provided the majority of the intellectual input and technical resources for this collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Ulm</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Dermatology and Allergic Diseases</gtr:department><gtr:description>Role of CD18 in neutrophil oxidase activation by bacteria and fungi</gtr:description><gtr:id>77890DE7-E8FE-43E6-89C2-BF55B510DA53</gtr:id><gtr:impact>PMID: 18755982 listed under 'publications'.
This collaboration also provided reagents for a current 'manuscript under review', which is listed under 'other outputs and knowledge'</gtr:impact><gtr:outcomeId>XGJsCpK35hf-1</gtr:outcomeId><gtr:partnerContribution>Access to CD18 knock-out mice</gtr:partnerContribution><gtr:piContribution>We provided the majority of the intellectual input and technical resources for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Semmelweiss University</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:department>Department of Physiology</gtr:department><gtr:description>Role of Syk in neutrophil activation by Aspergillus</gtr:description><gtr:id>137FFFC1-8A8F-4936-B386-616412B38CA7</gtr:id><gtr:impact>Boyle KB et al (2011) J Immunol. 186(5):2978-89. doi: 10.4049/jimmunol.1002268.</gtr:impact><gtr:outcomeId>Az1voaYWKub-1</gtr:outcomeId><gtr:partnerContribution>Our collaborators provided access to two strains of knock-out mice (syk KO; Fcgamma/DAP12 double KO) and hosted a visit from Keith Boyle (post-doctoral scientist employed on grant) to their laboratory in Budapest to conduct experiments.</gtr:partnerContribution><gtr:piContribution>We took the intellectual lead in this project and contributed the majority of the work and reagents, including strains of mice deficient in PI3K and NADPH oxidase subunits</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Role of the Fc gamma chain in neutrophil oxidase activation by bacteria</gtr:description><gtr:id>0657D6C7-798C-44A2-A7F8-36B99A7228B1</gtr:id><gtr:impact>PMID: 18755982 listed under 'publications'</gtr:impact><gtr:outcomeId>Dh5Sq5cMYUF-1</gtr:outcomeId><gtr:partnerContribution>provided access to Fc gamma chain knock-out mice</gtr:partnerContribution><gtr:piContribution>We provided the majority of the intellectual input and technical resources for this collaboration</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Role of Dectin-1 in neutrophil activation by Aspergillus</gtr:description><gtr:id>AFA2098A-F0B2-4991-89F3-79BFC955591B</gtr:id><gtr:impact>Boyle et al (2011) J Immunol. 186(5):2978-89. doi: 10.4049/jimmunol.1002268.</gtr:impact><gtr:outcomeId>FQ3hQBkbmTz-1</gtr:outcomeId><gtr:partnerContribution>access to Dectin-1 knock-out mice plus intellectual contribution to project</gtr:partnerContribution><gtr:piContribution>We took the intellectual lead in this project and contributed the majority of the work and reagents, including strains of mice deficient in PI3K and NADPH oxidase subunits</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>UCB Pharma</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>UCB pharma studentship</gtr:description><gtr:id>A5705DCF-7EDB-4037-804D-77A30B47230E</gtr:id><gtr:impact>PMID: 20813901 and PMID: 18755982 listed under 'publications'</gtr:impact><gtr:outcomeId>tUJ6M81a4db-1</gtr:outcomeId><gtr:partnerContribution>funded a PhD studentship that contributed to the project, also provided reagents and intellectual input</gtr:partnerContribution><gtr:piContribution>We provided the majority of the intellectual input and technical resources for this collaboration</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Semmelweiss University</gtr:collaboratingOrganisation><gtr:country>Hungary, Republic of</gtr:country><gtr:description>Mocsai - neutrophil biology</gtr:description><gtr:id>A6A4BCC5-0913-4035-A4A7-0FDEB69A3D86</gtr:id><gtr:impact>Gyori et al (2014) Arthritis Rheumatol. 66(8):2210-21. doi: 10.1002/art.38660
Boyle et al (2011) J Immunol. 186(5):2978-89. doi: 10.4049/jimmunol.1002268.

Research Grant from Karus Therapeutics, UK</gtr:impact><gtr:outcomeId>5461f4d9eae0a7.65874654-1</gtr:outcomeId><gtr:partnerContribution>expertise, reagents and exchange of personnel</gtr:partnerContribution><gtr:piContribution>expertise and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC National Institute for Medical Research (NIMR)</gtr:department><gtr:description>Role of Rac proteins in neutrophil oxidase activation by bacteria</gtr:description><gtr:id>82B541C4-8753-4DEB-9DE9-8B7D3D674E45</gtr:id><gtr:impact>PMID: 20813901 listed under 'publications'</gtr:impact><gtr:outcomeId>Wjjc7raTkJT-2</gtr:outcomeId><gtr:partnerContribution>Provided access to Rac1 knock-down and Rac2 knock-out mouse strains</gtr:partnerContribution><gtr:piContribution>We provided the majority of the intellectual input and technical resources for this collaboration</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Babraham Village Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>EFA375F6-2872-4C27-9A68-633A53396F91</gtr:id><gtr:impact>About 30 local parishioners attended a Q&amp;amp;A session at the Babraham Institute

I believe this activity helped inform local inhabitants about the medical research conducted at the Babraham Institute and hence helped to develop their opinions concerning local planning applications and also the activities of animal rights protestors.</gtr:impact><gtr:outcomeId>JGPgfxNhmQC</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>babraham lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>BEDA9155-58E0-4181-B572-3FB1AABDCB85</gtr:id><gtr:impact>Explaining our work to non-academic employees at the Babraham Institute through a formal lecture

a wider appreciation of MRC funded science at the Babraham Institute</gtr:impact><gtr:outcomeId>96DDB3A6621</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>schools day - Babraham</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>F0C2237F-D823-45ED-9562-DFBA00EBC97B</gtr:id><gtr:impact>We provided laboratory experiments based on our research for secondary school children (GCSE and A-level). Two groups of 5-7 children attended for one day each year. Three members of my team spent a total of about 10 hrs preparing for this event and were each fully occupied on the day.

Students report that they gained a real sense of what working in scientific research is like. Schools have always reported a favourable impact on pupls decisions to pursue science at both 'A-level' and degree level and return each year.</gtr:impact><gtr:outcomeId>C6257FB8EF1</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited lecturer to international meetings (average 2-3 per year)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>7BBEF2D1-8EE8-4DD7-97D2-F9FE71F912A3</gtr:id><gtr:impact>promoted discussions, collaborations

scientific collaborations, joint grants and publications</gtr:impact><gtr:outcomeId>546215ce564be0.43637759</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>Pre-2006,2006,2007,2008,</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>post-doctoral training award/Roberts Funding</gtr:description><gtr:end>2010-10-02</gtr:end><gtr:fundingOrg>Babraham Institute</gtr:fundingOrg><gtr:id>6022DEBA-FCDF-40F9-B8A5-3CFFBEFB7259</gtr:id><gtr:outcomeId>ojEq75GyJdo0</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>The generation by gene-targetting of a strain of mice in which both alleles of the p40phox subunit of the NADPH oxidase harbour an R58A knock-in mutation. This mutation blocks the interaction of this subunit with PtdIns3P, the lipid product of type III PI3K.</gtr:description><gtr:id>CF80447F-E66B-4F59-9349-4B84BA61CBD7</gtr:id><gtr:impact>PMID: 20813901 and PMID: 18755982 listed under 'publications'</gtr:impact><gtr:outcomeId>dmXq8BJUXau</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Generation of p40phoxR58A knock-in mice</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:url>http://europepmc.org/abstract/MED/20813901</gtr:url><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Assays were developed to measure neutrophil activation upon recognition of the hyphal form of the fungus Aspergillus Fumigatus. These included assays for the production of reactive oxygen species and the activation of PI3K signalling pathways.</gtr:description><gtr:id>A4FDE416-222E-4BD2-B514-FE2CA056A9E9</gtr:id><gtr:impact>Boyle et al (2011) J Immunol. 186(5):2978-89. doi: 10.4049/jimmunol.1002268.
PMID: 21257963</gtr:impact><gtr:outcomeId>Gr1x6wDZQsg</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Neutrophil activation by Aspergillus Fumigatus hyphae</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>46B9EB5D-ADD3-400A-A5CE-41AE572C2AC0</gtr:id><gtr:title>CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b69f958d0a381f3030849518250d3521"><gtr:id>b69f958d0a381f3030849518250d3521</gtr:id><gtr:otherNames>Anderson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>5AD7E83ED7C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DAE4BE5-B85E-4B4D-9F9F-CEA52F722D10</gtr:id><gtr:title>Activation of the neutrophil NADPH oxidase by Aspergillus fumigatus.</gtr:title><gtr:parentPublicationTitle>Annals of the New York Academy of Sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c32aa37418c9a82b85244eb7fe94dbe8"><gtr:id>c32aa37418c9a82b85244eb7fe94dbe8</gtr:id><gtr:otherNames>Boyle KB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0077-8923</gtr:issn><gtr:outcomeId>pm_13853_23_23230839</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB4DFF82-F0E1-4F64-A110-969968FF67FF</gtr:id><gtr:title>Class IA phosphoinositide 3-kinase ? and d regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c32aa37418c9a82b85244eb7fe94dbe8"><gtr:id>c32aa37418c9a82b85244eb7fe94dbe8</gtr:id><gtr:otherNames>Boyle KB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>tDhZZii53Xr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>04779E1E-75F8-4EF3-821D-971199737118</gtr:id><gtr:title>Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/64fe5298e413bf4a7ec0d211df7f07e7"><gtr:id>64fe5298e413bf4a7ec0d211df7f07e7</gtr:id><gtr:otherNames>Juss JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_13853_23_23029326</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBE1B76C-4967-4FA8-88DB-192699976537</gtr:id><gtr:title>PtdIns3P and Rac direct the assembly of the NADPH oxidase on a novel, pre-phagosomal compartment during FcR-mediated phagocytosis in primary mouse neutrophils.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b69f958d0a381f3030849518250d3521"><gtr:id>b69f958d0a381f3030849518250d3521</gtr:id><gtr:otherNames>Anderson KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>k4H4jy2LAho</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600840</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>